Quebec class action authorized against 16 pharma companies for role in opioid crisis
A class-action lawsuit has been authorized to proceed against 16 pharmaceutical companies for their role in manufacturing, selling, marketing and distributing opioid drugs in Quebec.
A class-action lawsuit has been authorized to proceed against 16 pharmaceutical companies for their role in manufacturing, selling, marketing and distributing opioid drugs in Quebec.
